The Enterprise Value as of November 2024 (TTM) for Evotec SE (EVO) is 1.30B

According to Evotec SE’s latest financial reports and current stock price. The company's current Enterprise Value is 1.30B. This represents a change of 6.55% compared to the average of 1.22B of the last 4 quarters.

Evotec SE (EVO) Historical Enterprise Value (quarterly & annually)

How has EVO Enterprise Value performed in the past?

The mean historical Enterprise Value of Evotec SE over the last ten years is 1.76B. The current 1.30B Enterprise Value has changed 7.29% with respect to the historical average. Over the past ten years (40 quarters), EVO's Enterprise Value was at its highest in in the December 2021 quarter at 7.03B. The Enterprise Value was at its lowest in in the June 2015 quarter at 333.89M.

Evotec SE (EVO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Evotec SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evotec SE (EVO) Average Enterprise Value

How has EVO Enterprise Value performed in the past?

The current Enterprise Value of Evotec SE (EVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evotec SE (EVO) Enterprise Value vs. Peers

How is EVO’s Enterprise Value compared to its peers?

Evotec SE’s Enterprise Value is less than Prestige Consumer Healthcare Inc. (5.20B), less than Supernus Pharmaceuticals, Inc. (2.00B), less than Collegium Pharmaceutical, Inc. (1.80B), less than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Eagle Pharmaceuticals, Inc. (24.78M), less than ANI Pharmaceuticals, Inc. (1.68B), greater than Phibro Animal Health Corporation (1.20B), greater than Pacira BioSciences, Inc. (1.21B), less than Dr. Reddy's Laboratories Limited (1.04T), greater than Silver Spike Investment Corp. (33.56M), greater than Regencell Bioscience Holdings Limited (73.51M), less than Neurocrine Biosciences, Inc. (12.62B),

Build a custom stock screener for Evotec SE (EVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evotec SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evotec SE (EVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evotec SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.